Work

Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline

Year: 2017

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2017.11.025

Authors: Victor Chedid, Priya Vijayvargiya, Michael Camilleri

Institution: Mayo Clinic

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Foundation for Anesthesia Education and Research, National Institutes of Health, U.S. Food and Drug Administration, National Institute of Diabetes and Digestive and Kidney Diseases

Award: G2924260561

OpenAlex ID: W2770477208

FWCI: 2.584

Cites: 24

Cited by: 59

Related to: 10